Skip to main content

Inozyme Pharma, Inc.

INZYDelisted Jul 1, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001693011

Inozyme Pharma, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 3, 2025; 87 institutions reported holding it in 13F filings for Q2 2025, worth $202.3M in total; no superinvestor held it.

Superinvestors holding INZY, Q2 2025

See all superinvestors

No superinvestor reported holding INZY in Q2 2025.